Fulgent Genetics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Fulgent Genetics, Inc. (FLGT) on November 4, 2022, covering the event date of October 31, 2022. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On October 31, 2022, Leonard Post notified the Board of Directors of his resignation. His departure is effective as of October 31, 2022, from the following positions:
- Member of the Board of Directors
- Chair of the Nominating and Corporate Governance Committee
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the announcement of the director's resignation.
Key Facts for Investor Verification
- Leonard Post has resigned from the Board and his committee chairmanship effective October 31, 2022.
- The resignation was reported by the Chief Financial Officer, Paul Kim.
- Investors should verify if a replacement director or committee chair has been appointed in subsequent filings.